CVE-2012-2151

Description

Multiple cross-site scripting (XSS) vulnerabilities in SPIP 1.9.x before 1.9.2.o, 2.0.x before 2.0.18, and 2.1.x before 2.1.13 allow remote attackers to inject arbitrary web script or HTML via unspecified vectors.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.43%
Vendor Advisory debian.org Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://exchange.xforce.ibmcloud.com/vulnerabilities/75104 vdb entry
http://www.openwall.com/lists/oss-security/2012/05/01/4 mailing list
http://www.securitytracker.com/id?1026970 vdb entry
http://archives.rezo.net/archives/spip-en.mbox/U5QUZ6WJRAJC7H5BR7W5SQG6WCD3PXL7/ mailing list
http://www.openwall.com/lists/oss-security/2012/04/30/4 mailing list
http://secunia.com/advisories/48939 third party advisory vendor advisory
http://www.osvdb.org/81473 vdb entry
http://www.securityfocus.com/bid/53216 vdb entry
http://www.debian.org/security/2012/dsa-2461 vendor advisory

Frequently Asked Questions

What is the severity of CVE-2012-2151?
CVE-2012-2151 has been scored as a medium severity vulnerability.
How to fix CVE-2012-2151?
To fix CVE-2012-2151, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2012-2151 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2012-2151 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.